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ABSTRACT
Epithelial attachment to the basement membrane (BM) is essential
for mammary gland development, yet the exact roles of specific
BM components remain unclear. Here, we show that Laminin α5
(Lama5) expression specifically in the luminal epithelial cells is
necessary for normal mammary gland growth during puberty, and
for alveologenesis during pregnancy. Lama5 loss in the keratin
8-expressing cells results in reduced frequency and differentiation
of hormone receptor expressing (HR+) luminal cells. Consequently,
Wnt4-mediated crosstalk between HR+ luminal cells and basal
epithelial cells is compromised during gland remodeling, and
results in defective epithelial growth. The effects of Lama5 deletion
on gland growth and branching can be rescued by Wnt4
supplementation in the in vitro model of branching morphogenesis.
Our results reveal a surprising role for BM-protein expression in the
luminal mammary epithelial cells, and highlight the function of Lama5
in mammary gland remodeling and luminal differentiation.
KEY WORDS: Laminin alpha 5, Extracellular matrix, Basement
membrane, Mammary gland, Luminal epithelial cell, Wnt4
INTRODUCTION
Postnatal development of the mammary gland occurs by branching
and elongation during puberty, and by extensive remodeling during
pregnancy (Macias and Hinck, 2012; Paine and Lewis, 2017). The
fully formed adult mammary epithelium consists of a bilayered duct,
in which apicobasally polarized keratin 8/18+ luminal cells, which
can be subdivided into hormone receptor-expressing and non-
expressing luminal cells (HR+ and HR−, respectively), face the ductal
lumen and are surrounded by keratin 5/14+ basal myoepithelial cells
(Macias and Hinck, 2012; Adriance et al., 2005).
The mammary microenvironment contributes to various properties
ofmammary epithelial cells (MECs), including proliferation, survival
and differentiation (Inman et al., 2015). In particular, attachment to
the specialized layer of the extracellular matrix (ECM) called the
basement membrane (BM) is crucial for cultured mammary epithelial
cells and for mammary gland morphogenesis in vivo (Inman et al.,
2015; Weaver et al., 1997; LaBarge et al., 2009). The BM acts as a
physical barrier separating the epithelium from the stroma and as a
scaffold supporting epithelial adhesion and tissue architecture
(Yurchenco, 2011). Moreover, the BM regulates tissue homeostasis
by supplying cells with growth factors and other signaling molecules,
and by regulating their availability to the cells (Yurchenco, 2011).
Laminins are the main components of the BM that together
with collagen IV form self-assembling networks, which provide
epithelial cells an anchoring platform and various survival and
differentiation signals (Hohenester and Yurchenco, 2013). Laminins
are heterotrimers consisting of α, β and γ subunits, which are expressed
in a tissue-specific and temporally controlled manner (Ahmed and
Ffrench-Constant, 2016). Several laminin isoforms have been detected
in the mammary gland, and earlier studies suggest that laminin-111
(containing α1, β1 and γ1 subunits), laminin-332 and laminin-511/521
are the most common forms in the adult glands (Goddard et al., 2016;
Gudjonsson et al., 2002; Prince et al., 2002), yet laminin-211 and
laminin-411/421 are also found.Microarray studies and later single-cell
sequencing efforts have indicated high expression of Lama1 and
Lama3 in the basal cells, with Lama5 being highest in luminal cells
(Lim et al., 2010; Bach et al., 2017; Tabula Muris Consortium, 2018).
However, what the spatial and temporal expression patterns of these
laminins within intact tissue are and what their exact roles in mammary
development and function are is unclear.
We set out to study the expression pattern and function of different
laminin isoforms in the mouse mammary gland. We demonstrate that
Lama5 produced by luminal cells is necessary for normal mammary
gland growth and development during both puberty and pregnancy.
Mechanistically, we show that Lama5 loss alters differentiation
of HR+ luminal MECs, and consequently their Wnt4-mediated
interactions with basal cells during gland remodeling. Our results
reveal that Lama5 acts as a key microenvironmental effector of
mammary gland function by orchestrating HR+ luminal cell
specification during puberty and pregnancy.
RESULTS
Differential expression of laminin isoforms in distinct cell
types of the mammary epithelium
To explore the role of specific laminins in the mammary gland, we
first studied their expression during the pubertal gland expansion,
which is marked by terminal end bud (TEB) structures (Macias
and Hinck, 2012). Using in situ hybridization (ISH) to detect
the expression of Lama1, 3, 4 and 5 (encoding the laminin α1, α3,
α4 and α5 subunits), we observed that both Lama1 and 3 were
expressed by the basal cells of growing TEBs (Fig. 1A) and
established ducts (Fig. S1A). Lama3 expression was also detected in
some luminal cells of the mature ducts (Fig. S1A, red arrowheads).
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In striking contrast, Lama5 was strongly expressed by luminal
epithelial cells, particularly in TEBs, and Lama4 showed
widespread expression also in stroma. As Lama1 and Lama5
showed the most cell type-specific expression patterns, we next
analyzed their expression during the pregnancy-induced gland
remodeling. Although separation of the two cellular layers is less
evident in the differentiated alveoli, Lama1 expression appeared to
be restricted to basal cells and Lama5 was mostly restricted to
luminal cells also during pregnancy (Fig. 1B). To quantitatively
address expression of Lama1 and Lama5 in the luminal and basal
MECs, we combined laminin ISH with keratin 8 (K8, also known
as Krt8) and keratin 14 (K14, also known as Krt14) antibody
staining in the pubertal glands (Fig. 1C; Fig. S1B,C). Whereas
Lama1was strictly expressed by basal (K8− and K14+) cells, Lama5
was significantly enriched in luminal (K8+ and K14−) epithelial
cells with some expression in a subset of basal cells (Fig. 1D; Fig.
S1C). Moreover, by further subdividing CD29low/CD24+ luminal
cells into HR− and HR+ with fluorescence-activated cell sorting
(FACS; Fig. S1D) by cell surface markers Sca1 (also known as
Ly6a) and CD49b (Shehata et al., 2012), we found that
HR-expressing luminal cells are the major source for Lama5 in
the mammary epithelium (Fig. 1E).
The expression of the BM component Lama5 in luminal cells was
surprising as luminal cells are reported to have only very limited
contacts with the BM (Smith and Medina, 1988; Lafkas et al.,
2013). However, the Pan-laminin staining that we observed mostly
in the periductal region suggested that the luminally expressed
laminin proteins are also deposited on the BM surrounding the
Fig. 1. Expression of laminin α chain isoforms in themammary gland is cell type-specific. (A) Representative images of RNA ISH performed with probes for
Lama1, 3, 4 and 5 on TEBs of 7-week-old pubertal mammary glands. (B) Representative images of RNA ISH of mammary glands from embryonic day 13.5
pregnant mice performed with probes for Lama1 and 5 on TEBs. (C) Representative images of Lama5 RNA ISH coupled with either K8 or K14 antibody staining.
Asterisk denotes background staining. The dashed boxes indicate the magnified regions in the lower panels. (D) Quantification of the percentage of K14+ or K8+
cells showing either Lama1 or Lama5 expression. Lama1 quantification in K14+ and K8+ cells (K14, n=23 ducts; K8, n=28 ducts; from three animals). Lama5
quantification in K14+ (n=29) and K8+ cells (n=31) ducts from three animals. Data points correspond to individual ducts analyzed. (E) qRT-PCR analysis of Lama5
expression compared with GAPDH in populations of stromal (St), basal (B), luminal HR+ and luminal HR− cells FACS sorted from mammary glands (St, n=3; B,
n=4; HR+, n=5; HR−, n=4 mice analyzed). Data aremean±s.d. An unpaired two-tailed Student’s t-test was used to compare indicated groups (*P<0.05, **P<0.01,
****P<0.0001). Scale bars: 50 µm (A); 50 µm (B); 20 µm.
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gland (Fig. S1E). Providing a potential route for luminal cells to
secrete laminins into the BM, we detected contacts between luminal
cells and the BM (Fig. S1F) in tamoxifen-induced Lgr6-CreERT2:
Rosa26-tdTomato mice in which clones of exclusively luminal or
basal cells can be visualized (Blaas et al., 2016). Taken together,
these results indicate that laminin isoforms have distinct expression
patterns within the mammary gland (summarized in Fig. S1G),
and also infer that the luminal epithelial cells, in addition to the
BM-adjacent basal cells, may contribute to the laminin pool of
the BM.
Laminin α5 is required for normal pubertal mammary gland
morphogenesis
To address the functional role of the luminally expressed Lama5, we
generated Lama5fl/fl;K8-CreERT2 mice (Nguyen et al., 2005;
Van Keymeulen et al., 2011), which allow tamoxifen-inducible
deletion of Lama5 in luminal epithelial cells. To determine the
effects of Lama5 loss during puberty, we injected 3-week-old
female mice with 1.5-2 mg of tamoxifen, and analyzed glands at 6,
8 or 10 weeks of age (Fig. 2A). Consistent with previous reports
(Shehata et al., 2014; Scheele et al., 2017), we observed a significant
decrease in epithelial growth and TEB number even with such a
low tamoxifen dose, forbidding use of higher doses (Fig. S2A).
To validate effective recombination, we first analyzed allelic
frequencies in FACS-sorted luminal and basal epithelial cells
3 days after tamoxifen treatment (Fig. S2B), and in bulk epithelial
cells 3 weeks after tamoxifen (Fig. S2C). Recombined Lama5 allele
was observed only from the luminal epithelial cells, and a high level
of recombination was evident 3 weeks after tamoxifen (Fig. S2B,C).
Moreover, allele-specific analysis of mRNA levels (Fig. S2D)
revealed an 88% reduction in the relative abundance of wild-type
mRNA in luminal epithelial cells sorted from tamoxifen-treated 8-
week-old Lama5fl/fl;K8-CreERT2 mice compared with Lama+/+;
K8-CreERT2 controls (Fig. 2A; Fig. S2E). Thus, stable and cell
type-specific deletion of Lama5 was achieved in the majority of the
luminal cells, even with the lower tamoxifen dose used.
Lama5 deletion in luminal MECs led to delayed development of
the mammary epithelium (Fig. 2B), which was accompanied by a
reduction in TEB size and number (Fig. 2C,D). Consequently, the
extent of the epithelial network was significantly reduced and
contained fewer Ki-67+ cells at 8 weeks (Fig. 2E,F). However, when
Lama5 was deleted in the post-pubertal mature glands of 8-week-
old mice and analyzed at 12 weeks of age, no difference in the ductal
end number was observed (Fig. S2F,G). These data suggest that
although Lama5 is required for mammary epithelium growth and
morphogenesis during pubertal remodeling, loss of Lama5 in adult
mammary glands has little effect on adult homeostasis.
To investigate whether the defective gland growth upon Lama5
targeting was due to impaired function of the Lama5-deleted
luminal cells, or due to their loss, we crossed Lama5fl/fl;K8-
CreERT2 mice with the R26-mTmG reporter line (Muzumdar et al.,
2007). Immunofluorescence analysis of the glands 3 weeks post
tamoxifen showed comparable frequencies of recombined cells in
Lama5fl/fl;K8-CreERT2;R26mT/mG and control mice (Fig. 2G,H;
Fig. S2H). Although recombination frequency of the reporter and
Lama5 loci may differ (Vooijs et al., 2001), these results are in line
with our analysis of recombination efficiency (Fig. S2E), and
indicate that Lama5-deficient cells are not lost and contribute to
blunted epithelial growth.
Interestingly, although parts of the ducts appeared ultrastructurally
normal, histological analysis of Lama5fl/fl;K8-CreERT2 glands at
8 weeks revealed a frequent loss of normal tissue architecture at
certain gland regions. The regional variability may reflect the
development of ducts before and after tamoxifen-induced Lama5
deletion, but even in blinded analysis of the full mammary gland,
aberrant ducts were significantly more frequent in Lama5-deficient
mice than in control mice (Fig. 2I). In the aberrant ducts, K8+ luminal
cells were atypically organized into multiple layers (Fig. 2J). These
observations suggested defects in cellular polarity in the Lama5-
deficient epithelium, and we therefore inspected the localization and
expression of apical polarity markers ZO-1 (also known as Tjp1) and
MUC1 (Fig. 2K). We noticed that even in the aberrant Lama5fl/fl;K8-
CreERT2 ducts localization of ZO-1 andMUC1was mostly marking
the apical surfaces facing the ductal lumens, similarly to controls
(Fig. 2K). However, Lama5fl/fl;K8-CreERT2 ducts showed great
variability in intensity and localization of the polarity markers,
suggesting that loss of Lama5 from the luminal epithelium affects
luminal cell polarity but the polarity is not completely lost.
Interestingly, both ZO-1 and MUC1 also exhibited a dramatic
reduction in general staining intensity in the Lama5-deficient ducts.
MUC1 is a differentiation marker of luminal mammary epithelial
cells (Shehata et al., 2012), raising the possibility of defective luminal
differentiation in Lama5-deleted glands. In conclusion, Lama5 in the
luminal epithelial cells is necessary for normal pubertal mammary
gland growth and properly polarized duct architecture.
Loss of laminin α5 compromises HR+ cell differentiation
The aberrant organization and reduction in luminal cell
differentiation marker MUC1 prompted us to investigate cellular
ratios of the Lama5-deficient mammary epithelium. We noticed a
significant increase in luminal (CD29low/CD24+) to basal (CD29hi/
CD24+) cell ratio in Lama5fl/fl;K8-CreERT2 glands in comparison
with controls (Fig. 3A,B; Fig. S3A,B). Interestingly, we also noted
a 1.7-fold relative increase in the Sca1−/CD49b+ luminal cell
subpopulation comprising HR− cells (Fig. 3C) (Shehata et al., 2012;
Sleeman et al., 2007) in Lama5-lacking animals. Moreover, the
remaining HR+ cells expressed Sca1 on a lower level (Fig. 3D,E).
This indicated that prepubertal loss of Lama5 compromises
specifically the pool of HR+ cells during pubertal gland growth.
To further investigate whether the expression of HR+ luminal
epithelial differentiation markers are altered in Lama5-deficient
glands, we performed qPCR on estrogen receptor alpha (Esr1),
progesterone receptor (PR, also known as Pgr) and Receptor
Activator of Nuclear factor Kappa B ligand (RANKL, also known
as Tnfsf11). Expression of all three markers of HR+ differentiation
in the Lama5-targeted luminal cells was reduced significantly
and beyond the level expected based on the observed reduction
in HR+ cell frequency (Fig. 3F, compare with Fig. 3C). These data
indicate that Lama5 is indeed necessary for HR+ luminal cell
differentiation and for maintaining a normal ratio of epithelial cells.
Laminin α5 is necessary for normal alveologenesis
We next assessed the role of Lama5 in the pregnancy-induced
growth and functional differentiation of the mammary gland.
Lama5 was deleted from the luminal cells of 8-week-old female
mice 1-2 weeks before pregnancy, and glands were analyzed
17.5 days post coitum (dpc; Fig. 4A; Fig. S4A). Alveolar
development was dramatically reduced in Lama5-deficient glands,
as evidenced by fewer and less densely packed alveoli compared
with control glands (Fig. 4A,B; Fig. S4B). Moreover, Lama5-
deficient alveoli often failed to form round structures, and were
instead devoid of distinct lumen and exhibited aberrant organization
of both luminal and basal cells (Fig. 4C). However, the apicobasal
polarity of Lama5-deficient glands appeared only modestly affected
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at this stage of pregnancy (Fig. 4D) yet, intriguingly, also at
this stage, MUC1 staining intensity was reduced. Analysis at
postpartum day 2 (PP2) revealed that alveoli in Lama5-deleted
glands were significantly smaller and exhibited disorganized
cellular organization, even though Pan-laminin staining indicated
that the BM remained intact (Fig. 4E,F). Again, cell polarity was
largely unaffected, as demonstrated by staining of ZO-1 and MUC1
(Fig. 4G). However, the Lama5-deficient females often had less
pups, which at this stage can also affect gland morphology.
Taken together, our characterization of the mouse model with
Fig. 2. See next page for legend.
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luminal-specific Lama5 deletion demonstrates an important in vivo
role for Lama5 in luminal MECs during the key stages of mammary
gland development and function.
Lama5-deficient HR+ luminal MECs are unable to support
basal cells
Ductal elongation during puberty and alveologenesis during
pregnancy both require accurate interplay between the luminal
and basal MECs (Macias and Hinck, 2012; Inman et al., 2015). HR+
luminal MECs are considered to orchestrate mammary growth and
development by responding to systemic hormonal cues and
transforming them into paracrine signals (Tanos et al., 2012).
Accordingly, prepubertal loss of Esr1 from luminal cells impedes
the development of the mammary epithelium during puberty
(Mallepell et al., 2006; Feng et al., 2007), and Esr1 loss during
pregnancy results in defective alveologenesis and milk production
(Feng et al., 2007). As Lama5 expression was highest in the luminal
HR+ cells (Fig. 1E), and luminal Lama5 loss reduced HR+ cell
frequency and differentiation, as well as Esr1, PR, and RANKL
expression (Fig. 3C-E), we hypothesized that defects in the growth
and differentiation of Lama5 lacking mammary epithelium are due
to compromised function of HR+ cells.
Wnt4 is an important paracrine mediator that is expressed in
the HR+ MECs in response to progesterone (Tanos et al., 2012).
Together with R-spondin 1 (Rspo1) from HR− luminal MECs,
Wnt4 activates Wnt signaling in the basal cells to regulate growth of
the mammary epithelium (Rajaram et al., 2015; Cai et al., 2014;
Brisken et al., 2000). Interestingly, expression of Wnt4 was
significantly reduced in Lama5-deficient luminal cells, whereas
Fig. 2. Luminal laminin α5 is required for pubertal growth of the mammary
epithelium. (A) Schematic showing the outline of tamoxifen induction of K8-
CreERT2 during puberty, and qPCR analysis of Lama5 mRNA expression in
luminal MECs (+/+ and fl/fl, n=4 samples analyzed) by using wild-type (WT)
allele-specific primers comparedwith primers common for both + and flox alleles
(common). (B) Representative images of carmine alum-stained #4 mammary
glands of 8-week-old Lama5+/+;K8-CreERT2 and Lamafl/fl;K8-CreERT2 treated
with tamoxifen. The dashed line shows the outline of ductal growth and the
asterisks mark the beginning of epithelium. (C) Representative images of TEBs
and ductal ends (marked by black arrowheads and red arrows, respectively) in
6-week-old transgenicmice. (D)Quantification of the number of TEBs in 6-week-
old transgenic mice analyzed from #4 mammary glands (K8-CreERT2, n=10;
Lama5+/+;K8-CreERT2, n=6, Lama5fl/fl;K8-CreERT2, n=9 glands analyzed).
(E) Quantification of epithelium length in 8-week-old transgenic mice analyzed
from #4 mammary glands (Lama5fl/fl; n=9, Lama5fl/fl;K8-CreERT2, n=11 glands
analyzed). (F) Quantification of Ki67 positivity in mammary glands of 8-week-old
transgenic mice (Lama5fl/fl; n=4; Lama5fl/fl;K8-CreERT2, n=8 individuals
analyzed). (G) Representative images of #4 mammary glands of 6-week-old
Lama5+/+;K8-CreERT2;R26mTmG/+ and Lama5fl/fl;K8-CreERT2;R26mTmG/+
mice. Images show proximal (closer to the beginning of epithelium) and distal
parts of the duct. (H) Quantification of green to red fluorescence ratio in proximal
and distal parts of the duct in Lama5+/+;K8-CreERT2;R26mTmG/+ and Lama5fl/fl;
K8-CreERT2;R26mTmG/+ mice (+/+ and fl/fl, both proximal and distal part, n=4
glands quantified). (I) Quantification of epithelial disorganization in ducts of
8-week-old Lama5+/+;K8-CreERT2 (n=8) and Lama5fl/fl;K8-CreERT2 (n=8)
animals. (J) Representative immunofluorescence images of 8-week-old
Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 glands immunostained with
K8 and K14 antibodies. Boxes indicate themagnified regions in the right panels.
(K) Representative immunofluorescence images of 8-week-old Lama5+/+;K8-
CreERT2 and Lama5fl/fl;K8-CreERT2 glands immunostained with ZO-1 or
MUC1, and K8 antibodies. Data points indicate analysis of individual mice.
Data are mean±s.d. *P<0.05, **P<0.01 [unpaired two-tailed Student’s t-test
(A,E,I) or Welch’s ANOVA test (D)]. Scale bars: 5 mm (B); 0.5 mm (C);
200 µm (G); 50 µm (J,K).
Fig. 3. Laminin α5 is needed for HR+ luminal epithelial cell identity. (A) Representative CD24/CD29 FACS plot showing relative amounts of lineage marker
negative luminal and basal MECs from 10-week-old Lama5fl/fl;K8-CreERT2 and control animals. Gating strategy for the same sample is shown in Fig. S3A.
(B,C) Quantification of the percentages of basal and luminal MECs (+/+, n=3; fl/fl, n=3 individuals analyzed) and (C) luminal HR+ and HR− subpopulations from
10-week-old Lama5fl/fl;K8-CreERT2 and control mice (+/+, n=6; fl/fl, n=6 individuals analyzed). Data points indicate samples analyzed from individual mice. (D)
Mean intensity of Sca1+ luminal population from Lama5fl/fl;K8-CreERT2 and controlmice. Data showmean from n=5 separate experiments, in which 3-4 individual
animals were analyzed per group. Data points indicate mean values from five separate experiments. (E) Representative Sca1-BV711 histograms of individual
Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 mice. (F) qRT-PCR analysis of Esr1, PR and RANKL expression compared with GAPDH in luminal MECs
from 10-week-old Lama5fl/fl;K8-CreERT2 and control mice (Esr1 +/+, n=5; fl/fl, n=4; PR +/+, n=9; fl/fl, n=8; RANKL +/+, n=4; fl/fl, n=3). Data points indicate
samples analyzed from individual mice. Data are mean±s.d. *P<0.05, **P<0.01 [unpaired two-tailed Student’s t-test (B,C,F); paired t-test (D)].
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Rspo1 showed only a trend of modest reduction (Fig. 5A; Fig. S5A).
Moreover, the expression of Wnt-responsive genes Sox9 and Lgr5
regulated directly via transcriptional control (Blache et al., 2004;
Schuijers and Clevers, 2012), or Ctnnb1 regulated via mRNA
stability (Bikkavilli and Malbon, 2010), was significantly reduced
in the basal cells (Fig. 5B). Jointly these data indicate that defects in
the HR+ cells after luminal Lama5 loss does indeed compromise the
luminal-basal interactions.
To directly test whether the altered paracrine Wnt signaling
contributes to the defective growth of the mammary gland after
luminal Lama5 loss, we modeled gland growth in vitro.
Ductal growth by the TEB structures can be modeled in vitro with
FGF-2 supplemented three-dimensional cultures, in which MEC
organoids form branching structures (Ewald et al., 2008). Under
these conditions, lentiviral CRISPR/Cas9-mediated Lama5 editing
resulted in Lama5 mRNA downregulation and a significant
reduction in organoid branch formation and elongation (Fig. 5C;
Fig. S5B,C), thereby resembling the effects of luminal Lama5
deficiency in vivo. Strikingly, exogenous addition of Wnt4 and
Rspo1 completely rescued the effects that Lama5 deletion had
Fig. 4. Laminin α5 is essential for pregnancy-induced growth and differentiation of themammary gland. (A) Schematic showing the experimental outline of
tamoxifen induction of K8-CreERT2 before pregnancy. Representative images of carmine alum-stained #4 mammary glands of 17.5 dpc pregnant Lamafl/fl;- and
Lamafl/fl;K8-CreERT2 animals. (B) Representative H&E images of 17.5 dpc pregnant Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 mice.
(C) Representative immunofluorescence images of 17.5 dpc pregnant Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 glands immunostained with
Pan-laminin and E-cadherin, or K8 and K14 antibodies. Square shows area of inset. (D) Representative immunofluorescence images of 17.5 dpc pregnant
Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 glands immunostained with ZO-1 or MUC1, and E-cadherin antibodies. (E) Quantification of the alveolar
diameter of 17.5 dpc (+/+, n=3; fl/fl, n=3 individuals analyzed) and PP2 mice (+/+, n=4; fl/fl, n=3 individuals analyzed). N=3-4 individual animals. Data points
represent mean alveolar diameter quantified from individual animals. (F) Representative immunofluorescence images of PP2 mammary glands immunostained
with K14 or Pan-laminin and E-cadherin antibodies. (G) Representative immunofluorescence images of PP2 mammary glands immunostained with ZO-1 or
MUC1, and E-cadherin antibodies. Data are mean±s.d. **P<0.01 (unpaired two-tailed Student’s t-test). Scale bars: 10 mm (A); 200 µm (B); 50 µm (C,D,F,G).
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on branching frequency (Fig. 5D,E). These effects are likely to
reflect the general activation of the canonical Wnt-pathway as
Wnt3a supplementation recapitulated the results seen with Wnt4
(Fig. S5D). Highlighting the role of Wnt signaling, inhibition of
Wnt production by porcupine inhibitor IWP-2 reduced the
branching of control organoids but had no further effects on
Lama5-edited organoids (Fig. S5D). In order to model the
phenotypes we observed in the mouse model more closely, and to
Fig. 5. See next page for legend.
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assess the cell type-specific effect of Lama5 in organoid growth, we
next isolated MECs from Lama5fl/fl;K8-CreERT2 and control mice
3 days after tamoxifen treatment (Fig. 5F). Such preparations
contain both luminal and basal cells, but Lama5 loss is exclusive to
luminal cells (Fig. S2B). Recapitulating results with lentiviral
targeting, branching frequency was decreased in organoids with
luminal-specific Lama5 deletion, and exogenous Wnt4 rescued the
branching defect (Fig. 5F,G). Moreover, branching was inhibited in
control and Lama5-deficient organoids with the addition of IWP-2.
These data further demonstrate that Lama5, specifically in luminal
cells, is necessary for branching morphogenesis via paracrine
signaling.
Targeting Lama5 or the rescue of branching with exogenous
Wnt ligands did not significantly change the frequency of Ki67+
cells (Fig. S5E), suggesting mechanisms other than proliferation.
When stained for K8 and E-cadherin to visualize the luminal
organoid structure, both lentivirally Lama5-edited and Lama5fl/fl;
K8-CreERT2 organoids showed similarly altered morphology with
blunted branching (Fig. 5H; Fig. S5F). However, upon Wnt4
treatment both formed elongated branches that contained K14-
expressing basal cells, and were structurally similar to branches in
control organoids (Fig. 5H,I; Fig. S5F,G). Further supporting the
role of Wnt signaling in promoting basal cell function during
branching, exogenous Wnt3a and Rspo1 also resolved the structure
of Lama5-deficient organoids (Fig. S5G).
Finally, to probe the possible interdependence of the in vivo
observed phenotypes on gland growth and differentiation during
pregnancy, we tested the lactogenic differentiation of organoids
lacking luminal Lama5. MECs were isolated from Lama5fl/fl;K8-
CreERT2 and control mice 3 days after tamoxifen, and organoids
were first grown in conditions inducing branching for 6 days
(Fig. 5J). Next, differentiation was induced with lactogenic medium
(LM) for an additional 6 days (Sumbal et al., 2020), leading to
a robust increase in the milk protein genes in control organoids
(Fig. S6A). Consistent with our in vivo results, loss of Lama5 led to
a decreased induction of Csn2 expression following the use of
lactogenic medium (Fig. 5J; Fig. S6B). However, although Wnt4
further increased Csn2 expression in controls, and it rescued the
branching defect of Lama5-deficient organoids as before, it did not
rescue the defective lactogenic induction in Lama5-deficient
organoids. Thus, although Wnt4 can resolve the defective
organoid morphology in Lama5-deficient organoids, it is not
sufficient to support the full functional differentiation of luminal
epithelium lacking Lama5.
In conclusion, our data suggest that downstream of attenuated
HR+ cell differentiation, loss of Lama5 in the luminal epithelium
results in defective gland growth due to altered interplay between
basal and luminal epithelial cells mediated by Wnt, and in defective
functionalization upon pregnancy (Fig. 6).
DISCUSSION
The mammary ECM is essential for normal physiology and
pathology of the mammary gland (LaBarge et al., 2009; Maller
et al., 2010; Goddard et al., 2016). However, the exact functions of
many specific BM constituents in mammary gland physiology have
remained unclear. Here, we show that BM laminin subunits α1, α3,
α4 and α5 exhibit distinct gene expression patterns in the luminal,
basal and stromal compartments of the mammary gland. We
discovered that Lama5 is predominantly expressed in the HR+
luminal epithelial cells, and when Lama5was deleted in the luminal
cells at various stages, we found that it has a critical role during
pubertal growth and pregnancy-induced remodeling and growth.
Our results are in concert with previous studies showing that the
downregulation of laminin-binding adhesion receptors, including
β1- and β4-integrins, results in the inhibition of mammary epithelial
growth and alveologenesis (Li et al., 2005; Naylor et al., 2005;
Walker et al., 2020; Romagnoli et al., 2020). Together, these data
underline the importance of laminin and BM microenvironment in
the regulation of mammary epithelial growth and differentiation.
The growth of the mammary epithelium occurs in a coordinated
manner, requiring interplay between both luminal and basal cell types
(Macias and Hinck, 2012; Inman et al., 2015). HR+ cells have been
indicated as essential mediators of this interplay by sensing systemic
hormones and producing paracrine signals for the neighboring HR−
luminal cells and the basal cells (Tanos et al., 2012). We observed a
moderate reduction in the number of HR+ luminal epithelial cells in
the Lama5-deficient mammary epithelium, but a more marked
reduction in the HR+-specific expression of Esr1, PR and RANKL.
Additionally, Sca1 marking both HR+ cells and their progenitors
(Sleeman et al., 2007; Shehata et al., 2012), showed a decrease after
Lama5 loss. These data suggest qualitative changes in the Lama5-
deficient HR+ luminal cells, which we postulate impairs their
capability to sense and respond to systemic and paracrine signals.
Previous studies have established Wnt signaling as an important
mediator of the interactions between HR+ and basal epithelial cells to
induce mammary epithelial growth (Zeng and Nusse, 2010; Rajaram
et al., 2015; Cai et al., 2014). We show that Lama5-deficient luminal
cells produce lessWnt4, which is expressed specifically byHR+ cells,
and functions as a downstream effector of Esr1 and PR (Cai et al.,
2014; Rajaram et al., 2015). We also demonstrate decreased
Fig. 5. Lama5-deficient luminal MECs are unable to support basal MECs
due to defective Wnt signaling. (A) qRT-PCR analysis of Wnt4 expression
compared with GAPDH in basal (CD29hi/CD24+) and luminal (CD29low/
CD24+) MECs FACS sorted from 8-10-week-old Lama5+/+;K8-CreERT2 and
Lama5fl/fl;K8-CreERT2 glands treated with tamoxifen starting from 3 weeks of
age (+/+ luminal and basal, fl/fl basal, n=3; fl/fl luminal, n=4 samples analyzed).
(B) qRT-PCR analysis of Sox9, Ctnnb1 and Lgr5 expression compared with
GAPDH in basal MECs from 10-week-old Lama5fl/fl;K8-CreERT2 and control
mice (Sox9 and Ctnnb1 +/+, n=8; fl/fl, n=10; Lgr5 +/+, n=7; fl/fl, n=7 samples
analyzed). In A and B, data points indicate RNA samples analyzed from
individual mice. (C) Primary MMECs carrying either LAMA5 or SCRACRISPR
guides (gLAMA5 and gSCRA) grown in Matrigel in the presence of 2.5 nM
FGF-2 for 4 or 10 days, and quantification of the percentage of branching
organoids at day 10 (gSCRA, n=3; gLAMA, n=3). (D) gLAMA5 or gSCRA
expressing primary MMECs grown in Matrigel in the presence of 2.5 nM FGF-2
and either Wnt4, Rspo1 or both ligands for 7 days. (E) Quantification of the
percentage of branching organoids at day 7 grown as in D (all treatments n=3).
(F) Schematic showing the outline of tamoxifen induction and representative
images. MECs were isolated from 10-14-week-old Lama5+/+;K8-CreERT2 and
Lama5fl/fl;K8-CreERT2 mice treated with tamoxifen 3 days earlier, and grown
in Matrigel in the presence of 2.5 nM FGF-2 and either Wnt4 or IWP-2 for
7 days. (G) Quantification of the percentage of branching organoids at day 7
grown as in F (all treatments n=4). In C, E and G, data points indicate RNA
samples analysed from individual mice. (H) Representative keratin 8 and
E-cadherin immunofluorescence images of primary MMECs organoids
treated as in F and grown for 7 days. (I) Representative keratin 14
immunofluorescence images of primary MMECs organoids expressing either
gLAMA5 or gSCRA treated as in D and grown for 7 days. (J) Schematic
showing the outline of organoid treatment with lactogenic medium. Quantitative
PCR analysis of Csn2 gene expression in MECs isolated from 10-14-week-old
Lama5+/+;K8-CreERT2 and Lama5fl/fl;K8-CreERT2 mice treated with
tamoxifen 3 days earlier, and grown as described in the schematic with or
without Wnt4 (all treatments n=3). Data are normalized to lactogenic medium-
treated Lama5+/+;K8-CreERT2 for each experiment. Data points indicate RNA
samples analysed from independent organoid experiments. Data are mean
±s.d. *P<0.05; **P<0.01; ns, not significant [unpaired one-tailed (J) or two-
tailed (A,B,C,E,G) Student’s t-test]. Scale bars: 100 µm (C,D,H); 50 µm (I).
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expression of Wnt target genes Lgr5, Ctnnb1 and Sox9 in the basal
epithelial cells of Lama5-deficient epithelia. Moreover, in our in vitro
studies, exogenous administration of Wnt4 rescued organoid
branching defects caused by Lama5 loss. Thus, we conclude that
the altered luminal-basal interactions, which are mediated by Wnt
signaling, can in part explain the defective growth and remodeling of
Lama5-deficient glands.
Loss of Lama5 from the adult mammary epithelium prior to
pregnancy led to reduced growth and defective differentiation of
alveoli during pregnancy-induced functionalization. Correspondingly,
downregulation of Lama5 in vitro led to defective lactogenic
differentiation in organoid cultures. Intriguingly, in these settings,
the addition of Wnt4 was unable to rescue the differentiation defect,
suggesting a lack of other essential factors. Expansion of luminal
epithelial cells during pregnancy is largely attributable to HR−
epithelial cells (Van Keymeulen et al., 2017), presumably mostly in
response to progesterone-mediated signals from HR+ cells (Brisken
et al., 1998). Therefore, it is interesting to hypothesize that the
paracrine signaling between HR− and HR+ cells is also impaired
in Lama5 lacking epithelium. Indeed, we observed that RANKL,
which is expressed by the HR+ cells downstream of progesterone
(Fata et al., 2000; Asselin-Labat et al., 2010), was significantly
downregulated in the Lama5-deficient epithelial cells. Furthermore,
loss of RANKL has been shown to inhibit alveologenesis and
lactogenic differentiation (Fata et al., 2000), which could underlie
the Lama5-dependent deficiency in lactogenic differentiation
observed in vitro. However, the small number of HR+ cells shown
to be present in the pregnant mammary gland (Van Keymeulen et al.,
2017) could in part explain the moderate phenotype observed in
pregnant glands.
Lama5 deficiency also affected the ductal epithelial organization
in puberty and pregnancy. Our results imply that the Lama5-
deficient luminal cells proliferate, albeit less than cells in control
glands, but fail to maintain normal contacts with the BM. This may
result in the observed accumulation of cells filling the gland lumen.
Luminal-ECM interactions are necessary for alveolar differentiation
and, thus, functionalization and milk secretion (Inman et al., 2015;
Streuli et al., 1995; Roskelley et al., 1994). Indeed, mammary
epithelia lacking the adhesion receptor β1-integrin exhibit defective
apicobasal polarization, surplus luminal cells within the ducts and
impaired alveolar cell function (Naylor et al., 2005; Akhtar and
Streuli, 2013). We noted that apicobasal polarity is affected also in
the Lama5-deficient luminal epithelial cells, suggesting it may
contribute to the surplus of luminal cells during puberty. Cell
polarity was better conserved in the Lama5-deficient glands during
pregnancy, suggesting the most aberrant glands may not be able to
contribute to pregnancy-induced gland remodeling. However,
addressing the exact order of events downstream of Lama5
deletion and loss of tissue architecture during puberty requires
further experiments.
Finally, how adhesion to Lama5-encoded Lama5 regulates Wnt4
signaling, and why particularly HR+ cells are influenced by Lama5
loss remain as open questions. As HR+ cells express more Lama5
than HR− luminal cells (Tabula Muris Consortium, 2018), and HR+
are responsive to systemic cues, it is attractive to postulate that they
require Lama5-mediated contacts with the BM in order to sense
the systemic hormonal signals. HR+ luminal cells also express,
for example, Integrin b4 (Itgb4) capable of adhering to Lama5
(Yurchenco, 2011), whereas Itgb4 expression in HR− cells is lower
(Tabula Muris Consortium, 2018). The slender projections of
luminal cells that we noted reaching past basal cells may therefore
represent an HR+ cell-specific feature of the luminal layer.
Taken together, our data suggest that Lama5 loss in the mammary
epithelium results in adhesion and organization defects of luminal
MECs, leads to a deficient HR+ luminal MEC pool with insufficient
capability to sustain luminal-basal interactions, and gland
remodeling in puberty and pregnancy. Further experiments are
required to address whether additional functions of Lama5 partake
mammary gland biology in vivo and whether the mechanisms
described here contribute to pathologies with distorted tissue
organization, such as cancer.
MATERIALS AND METHODS
Animals
Animal studies were approved by the National Animal Ethics Committee of
Finland and conducted in the Laboratory Animal Center of the University of
Helsinki under institutional guidelines or approved by the ethics committee
of the Board of Agriculture, Experimental Animal Authority, Stockholm,
Sweden. The Lama5 fl mouse was a kind gift from Dr Jeffrey Miner
(Nguyen et al., 2005). Lgr6-EGFP-IRES-CreERT2, Rosa26-tdTomato, K8-
CreERT2 and R26-mTmG mouse lines have been described previously
(Muzumdar et al., 2007; Van Keymeulen et al., 2011; Nguyen et al., 2005;
Blaas et al., 2016). Genotyping of the animals was performed using primers
described previously. Excised Lama5 allele was detected using the
following primers: Fwd, 5′-ACCTGGCTTTGACGGTCCT-3′; Rev, 5′-
GTTGAAGCCAAAGCGTACAGCG-3′. All animals used were females
between 6 and 20 weeks of age at the time of sacrifice. For Lgr6-Cre
Fig. 6. Working model of how
luminal Lama5 regulatesmammary
epithelial growth and crosstalk.
Schematic showing how the
production of LMα5 by luminal MECs
supports specifically the HR+ luminal
cells, in which it enhances gene
expression of ER, PR, Wnt4 and
RANKL. The products of these genes
then act on neighboring basal and
HR− epithelial cells to orchestrate
epithelial growth and morphogenesis
during puberty and pregnancy.
Deficiency of LMα5 in the BM
environment in turn leads to reduced















induction, a single dose of 1 mg tamoxifen (Sigma-Aldrich) in 50 µl
sunflower oil (Sigma-Aldrich) was injected intraperitoneally in 2-week-old
mice. For K8-CreERT2 induction, a single dose of 1.5-2 mg tamoxifen in
corn oil (Sigma-Aldrich) was injected intraperitoneally in 3-week-old mice,
and 5 mg of tamoxifen in 8-week-old mice.
RNA in situ hybridization
Gene expression analysis by RNA ISH was performed using an RNAscope
2.5 HD Reagent Kit-Brown or an RNAscope Multiplex Kit (Advanced
Cell Diagnostics Srl) according to manufacturer’s instructions. Paraffin-
embedded sections (5 µm) were deparaffinized, rehydrated and pretreated
with RNAscope Target Retrieval Reagents. A barrier was created around
each tissue section on the slides, dried overnight and used the following day.
Pretreated samples were hybridized with either laminin α1, α3, α4 or α5
probes (custom made by Advanced Cell Diagnostics) for 2 h at 40°C.
Thereafter, signal amplification hybridization was performed, followed by
detection with DAB (3,3′-diaminobenzidine) and counterstained with
Hematoxylin. Alternatively, when a Multiplex Fluorescent assay was used,
after signal amplification hybridization, the slides were immunostained
with primary antibodies (K8, 1:1000, TROMA-1, Developmental Studies
Hybridoma Bank; K14, 1:2000, BioLegend, PRB 155P) for 1 h. Thereafter,
samples were washed three times with PBS, 5 min each, and incubated with
secondary antibodies in 10% normal goat serum in immunofluorescence
buffer for 1-2 h. Slides were next washed three times, followed by
counterstaining of nuclei with DAPI and mounting. Samples were imaged
using a Zeiss Axio Imager.M2 and AxioCam HRc camera using Plan
Neofluar 20× (NA 0.5) or Plan Apochrom 63× (NA 1.4, oil) objectives and
Zen software, or using a Nikon Inverted widefield system with a 60× Plan
apochromat objective (NA 1.2, water) and Andor Xyla 4.2+ camera, and
NIS elements software (Nikon).
Whole-mount stainings
Mammary gland tissue samples for whole-mount staining were fixed in 4%
paraformaldehyde (PFA) overnight. For whole-mount staining, #4 inguinal
mammary glands were stained for several hours in carmine-alumn staining
solution (2% w/v Carmine, Sigma-Aldrich; 5% w/v aluminum potassium
sulfate, Sigma-Aldrich). After the desired color had developed, glands were
mounted to glass coverslips and imaged.
For whole-mount imaging and immunostaining of Lgr6-CreERT2;
Rosa26-tdTomato or Lama5 fl;K8-CreERT2;Rosa26-mTmG mammary
glands, the dissected mammary glands were pre-fixed in 4% PFA for
30–60 min at room temperature to preserve native fluorescence. For whole-
mount immunostaining, the tissue was permeabilized with two washes of
PBS0.5T (PBS plus 0.5% v/v Triton X-100) for 1 h, and the samples were
incubated overnight at 4°C with primary antibody against keratin 14 (1:500,
BioLegend PRB 155P) diluted in PBD0.2T [PBS, 1% bovine serum
albumin (BSA), 1% v/v DMSO and 0.2% v/v Triton X-100]. The next day,
they were washed four times with PBD0.2T for 1 h. Tissues were incubated
with secondary antibodies plus DAPI (Roche) at 4°C overnight. After four
washes with PBD0.2T for 1 h, tissues were optically cleared in 80% glycerol
in PBS at room temperature. The stained mammary glands were mounted
between two cover slips and sealed with silicone. Imaging of the whole
mounts was performed using a Zeiss LSM710 confocal microscope. A dry
lens (5×, EC Plan Neofluar, NA 0.16) or a water immersion lens (20× W
Plan Apochromat NA 1.0 or 40× C-Apochromat, NA 1.2) was used to
record optical sections at 512×512, 1024×1024 or 2048×2048 pixels, and
data were processed using ZEN software (Zeiss). Images were converted to
RGB images with ImageJ software.
Morphometric analysis of the mammary gland
For quantification of the number of terminal end buds (TEB) and ductal ends
in the mammary glands and the length of the epithelium, #4 mammary
glands stained with carmine-alumn whole mount were imaged using a Leica
S9i stereomicroscope equipped with an integrated 10 MP camera. The
amount of TEBs and ductal ends was quantified from the images based on
morphology. The length of the epithelium was measured from the same
images using ImageJ with its line tool. The length of the whole epithelial
network was recorded.
For quantification of ductal density, images of Hematoxylin and Eosin
(H&E)-stained pregnant mammary glands were acquired using a Leica
Microscope DM2000 with a Leica MC 190 HD camera with an N Plan 10×
objective. The percentage of ductal density was quantified from 10× images
by applying a series of Gaussian filtering and thresholding for brightness to
separate stained tissue area from the lumen and surrounding adipose tissue
using a custom Java script that can be obtained from the authors. The ratio of
the red channel to the other channels, balanced with the brightness, was used
to further separate Hematoxylin-stained nucleus-rich ductal tissue from
Eosin-stained connective tissue, and produce a binary image. A size-based
filter was applied to remove single nuclei and debris. The remaining area
representing the ducts was calculated for each tissue slide.
Tissue immunostainings
Mammary gland tissue samples for immunostaining were fixed in 4% PFA
overnight and embedded in paraffin for sections. For H&E stainings, 5 µm
sections were used. Stainings were performed in the Finnish Center for
Laboratory Animal Pathology (FCLAP) at the University of Helsinki.
Imaging for representative images was performed using a Pannoramic 250
Flash II high-throughput brightfield scanner (3DHISTECH) with a 20× (NA
0.8) objective and Pannoramic Viewer software.
For immunofluorescence stainings, 6-8 µm sections were deparaffinized and
rehydrated, and antigen retrieval was performed with 1 mMEDTA for 5-8 min
in a microwave oven, followed by 20 min incubation at room temperature.
Thereafter, non-specific binding sites were blocked with 10% normal goat
serum (NGS, Gibco) in PBS for 30 min at room temperature. Next, samples
were incubated with primary antibodies (pan-laminin 1:500, Abcam, ab11575;
K14, 1:500, BioLegend, PRB 155P; K8, 1:1000, TROMA-1, Developmental
Studies Hybridoma Bank; Ki-67, 1:500, Abcam, ab15580; E-cadherin 36/E,
1:500, BD 610181; ZO-1, 1:500, Thermo Fisher Scientific, 61-7300; and
MUC, 1:500, Abcam, ab15481) overnight at 4°C. The next day, samples were
washed three times with PBS, 5 min each, and incubated with secondary
antibodies in 10% NGS in PBS for 1-2 h. Thereafter, samples were washed
three times with PBS, 5 min each, followed by counterstaining of nuclei with
Hoechst 33342 (Sigma-Aldrich). All slides were mounted using Immu-Mount
(Thermo Scientific) mounting reagent. Images were acquired using a Leica
TCS SP8 STED 3X CW 3D confocal with an HC PL APO 63× water (NA
1.20) motCORR CS2 objective and LAS AF software, or a Leica SP8 upright
confocal microscope with an HC PLAPO 63× glycerol (NA 1.3) objective and
LAS AF software. The same settings for laser power and detector gain were
maintained within one experiment.
Quantification of fluorescence in mammary gland whole mounts
Mammary gland whole mounts of Lama5+/+;K8-CreERT2;Rosa26-mTmG
and Lama5fl/fl;K8-CreERT2;Rosa26-mTmG were imaged for 3-5 proximal
and distal areas of the mammary epithelium. Z-stacks were converted to Z
projections using the sum slice method. Regions of interest (ROI) were
drawn to encompass the epithelium and three spots were drawn to quantify
the background fluorescence. The integrated density of green and red
channels of ROIs was measured, and mean background fluorescence was
subtracted from the epithelial ROIs. From these values, the green to red
fluorescent ratio was calculated for both proximal and distal areas. Data are
shown as mean per mammary gland.
FACS analysis and sorting of primary MMECs
Single-cell suspension of isolated primary mouse mammary epithelial cells
(MMECs) was resuspended in 0.2% BSA in Dulbecco’s PBS, and the cells
were incubated with the following primary antibodies for analysis: CD29-
FITC (Miltenyi Biotech, 130-102-975); CD24-APC (M1/69, BioLegend,
101814); CD31-BV421 (MEC13.3, BD Biosciences, 562939); CD45-
BV421 (30 F11, BD Biosciences, 563890); Ter119-BV421 (BD
Biosciences, 563998); Sca1-BV711 (D7, BioLegend, 108131); and
CD49b-PE (HMα2, BioLegend, 103506). All antibodies were diluted
1:500 at 4°C for 30 min. Cells were washed with PBS and resuspended in
0.2% BSA in Dulbecco’s PBS with 1:500 Sytox Blue (Life Technologies,
Thermo Fisher Scientific) to exclude dead cells. Sorting was performed
using a FACSAria Fusion cell sorter (Becton Dickinson). FlowJo V10 was
used for post-analysis of sorted cells.
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RNA isolation and qPCR
RNA isolation was performed using an RNeasy isolation kit (Qiagen)
combined with On-Column DNase digestion (Qiagen), or using TRIzol
(Life Technologies, Thermo Fisher Scientific; from FACS-sorted cells)
according to manufacturer’s instructions. TRIzol-isolated RNA was treated
with DNase I (Thermo Fisher Scientific) according to manufacturer’s
protocol. cDNA synthesis was performed using a Revert Aid cDNA
synthesis kit (Thermo Fisher Scientific) starting with 250 or 500 ng of
RNA. Quantitative PCR reaction was performed using Power SYBR green
master mix (Applied Biosystems) and a Bio-Rad CFX384 Touch Real-Time
PCR detection system. Data were analyzed using a Bio-Rad CFX Manager
program. Relative mRNA amounts were assayed by comparing PCR cycles
to GAPDH using the ddCT method and normalizing to control samples.
The following primers were used: mGAPDH fwd, 5′-AAGGTCGGAGT-
CAACGGATT-3′; mGAPDH rev, 5′-TTGATGACAAGCTTCCCGTT-3′;
mLama5 WT fwd, 5′-GGGTGGAGTTACTGAGTGCC-3′; mLama5
WT rev, 5′-AGCTACGGCAGCCAAAGTAG-3′; mLama5 Common
fwd, 5′-GCCAGCAAGGCGATCCAAG-3′; mLama5 Common rev, 5′-
CCTGGTCTACGCTGAACACA-3′; mESR1 fwd, 5′-CCTCCCGCCT-
TCTACAGGT-3′; mESR1 rev, 5′-CACACGGCACAGTAGCGAG-3′
(Harvard Primer Bank ID, 6679695a1); mPR fwd, 5′-CTCGGACG-
TGTCGTCTGTAG-3′; mPR rev, 5′-CCTGTCTTTCCGTCTGGGAG-3′
(Harvard Primer Bank ID, 112363097c1); mRANKL fwd, 5′-CGCTCT-
GTTCCTGTACTTTCG-3′; mRANKL rev, 5′-GAGTCCTGCAAATC-
TGCGTT-3′ (Harvard Primer Bank ID, 114842414c2); mWnt4 fwd, 5′-
GTACCTGGCCAAGCTGTCAT-3′; mWnt4 rev, 5′-CTTGTCACTG-
CAAAGGCCAC-3′; mRspo1 fwd, 5-TTCTGCTGGAGAGGAACGAC-
3′; mRspo1 rev, 5′-GCCTCACAGTGCTCGATCTT-3′; mLgr5 fwd,
5′-ACCCGCCAGTCTCCTACATC-3′; mLgr5 rev, 5′-GCATCTAGGCG-
CAGGGATTG-3′; mSox9 fwd, 5′-GAGCCGGATCTGAAGAGGGA-3′;
mSox9 rev, 5′-GCTTGACGTGTGGCTTGTTC-3′; mCtnnb1 fwd,
5′-TGACTAGGGCTCAGAGGGTC-3′; and mCtnnb1 rev, 5′-TCAGCT-
CAGGAATTGCACGT-3′.
Primary cell isolation and culture
Primary MMECs were isolated from 10-16-week-old virgin female mice,
unless otherwise stated. Mammary glands #3-#5 were dissected, and the
lymph node in #4 glands was removed and the glands were finely chopped.
Tissuewas incubated with 0.01 mg of CollagenaseA (Sigma-Aldrich) per 1 g
of tissue in Dulbecco’s modified Eagle medium (DMEM)/F12 growth
medium (Life Technologies) containing 2.5% fetal calf serum (FCS), 5 µg/ml
insulin, 50 µg/ml gentamicin and 2 mM glutamine with gentle shaking
(120 rpm in an environmental shaker) at 37°C for 2 h. The resulting cell
suspension was then first centrifuged at 400 g for 10 min and consecutively
pulse-centrifuged 3-5 times 400 g to yield preparation free of cells other than
MMEC organoids. Next, organoids were trypsinized with 0.05% Trypsin-
EDTA (Difco, J.T. Baker) for 5-10 min to obtain smaller organoid units and
drained through a 70 µm cell strainer (Becton Dickinson), and resuspended in
MMEC growth medium [DMEM/F12 medium containing 5 µg/ml insulin,
1 µg/ml hydrocortisone, 10 ng/ml mouse EGF, 2 mM glutamine, 50 µg/ml
gentamycin and penicillin and streptomycin (all from Sigma-Aldrich)
supplemented with 10% FCS (Gibco)].
Lentiviral virus production and infection
Lentiviruses were produced in 293fT cells (Thermo Fisher Scientific;
regularly tested for mycoplasma contamination) grown in DMEM
(Sigma-Aldrich) supplemented with 10% FCS (Gibco), Penicillin/
Streptomycin (Orion/Sigma-Aldrich) and 2 mM glutamine (Sigma-
Aldrich). Transfections of transfer vector (pLentiCRISPRv2 gSCRA,
pLentiCRISPRv2 gLAMA5) and packaging plasmids (CMV-VSVg and
Delta8.9) were performed using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. To concentrate lentiviral particles,
medium from transfected cells was harvested 72 h post-transfection and
concentrated by ultracentrifugation at 87,000 g for 120 min (Sorvall
Discovery 90SE Ultracentrifuge). The viral pellet was then resuspended in
PBS at a ∼300-fold concentration and left to dissolve at 4°C for 18 h. Viral
titer was determined using a p24 ELISA test measuring viral capsid protein
p24 (Perkin Elmer, performed in the Biomedicum Functional Genomics
Unit). Primary MMECs were infected on 24-well low adhesion plates
overnight using multiplicity of infection 5 in an 800 µl volume and washed
with growth medium the next day.
Plasmid construction for CRISPR guides
CRISPR guides were designed to target LAMA5 using the CRISPR Design
tool (http://crispr.mit.edu). The following target sequences were used:
gLAMA5, 5′-CCATCGATGGCACGGAGCGC-3′, and gSCRA, 5′-
CTAAAACTGCGGATACAATC-3′. Oligos with target sequences were
designed according to instructions published previously (Shalem et al.,
2014), annealed and cloned into the pLentiCRISPRv2 vector.
Three-dimensional organotypic cell culture assays
Three-dimensional organotypic culture was performed in growth factor-
reduced BM from Engelbreth–Holm–Swarm mouse sarcoma (Matrigel,
Becton Dickinson), which was prepared according to the manufacturer’s
instructions. Isolated primary MMECs grown on low adhesion plates were
trypsinized with 0.05% Trypsin-EDTA for 5-10 min, centrifuged and
suspended with liquid Matrigel, and plated onto 8-well chamber slides at
∼1500 cells/well. Organoids were grown in DMEM/F12 supplemented with
ITS medium supplement (Sigma-Aldrich), penicillin and streptomycin and
2.5 nM FGF-2 (Sigma-Aldrich). Wnt3a and Wnt4 (both R&D Biosystems)
were used in 100 ng/ml, Rspo1 (R&D Biosystems) in 500 ng/ml, and
porcupine inhibitor IWP-2 (Sigma-Aldrich) in 2 µM, and were added on the
starting day of the cultures. Medium was refreshed every 3-4 days. For
lactogenic differentiation, organoids were first grown for 6 days in the
DMEM/F12 medium supplemented with 2.5 nM FGF-2, ITS and penicillin
and streptomycin, and thereafter, 6 days in the same culture medium
additionally supplemented with 1 μg/ml mouse prolactin (Sigma-Aldrich)
and 1 μg/ml hydrocortisone (Sigma-Aldrich).
Three-dimensional organoid immunofluorescence staining
and imaging
Three-dimensional organoids were fixed with 2% PFA for 20 min at room
temperature and thereafter washed with PBS. Organoids were permeabilized
with 0.25% Triton X-100 in PBS for 10 min at 4°C, and thereafter washed
with PBS. The non-specific binding sites were blocked with 10% normal
goat serum (Gibco) for 1-2 h. The primary antibodies (keratin 14, Covance,
1:300; Keratin 8, TROMA-1, 1:300; Ki-67, Abcam, 1:500) were incubated
in the blocking solution overnight at 4°C. Following the incubation,
structures were washed three times with PBS, 15 min each wash, and then
incubated with appropriate Alexa Fluor secondary antibody diluted in
blocking solution. After 40-50 min incubation at room temperature, the
structures were washed with IF buffer as before and the nuclei were
counterstained with Hoechst 33342. All slides were mounted using Immu-
Mount (Thermo Scientific) mounting reagent. Images were acquired using a
Leica TCS SP8 STED 3XCW3D confocal microscopewith an HC PLAPO
63× water (NA 1.20) motCORR CS2 objective and LAS AF software, or a
Leica SP8 Upright confocal microscope with an HC PL APO 63× glycerol
(NA 1.3) objective.
Quantification and statistical analysis
Data are presented as mean±s.d. from at least three independent experiments
or three individual animals quantified, unless otherwise stated in the figure
legend. An unpaired two-tailed Student’s t-test was used to compare two
groups, unless otherwise stated in the figure legend. Statistical tests were
performed using GraphPad Prism 8.
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